Keyphrases
Metastasis
100%
Immunosuppression
100%
Tumor-draining Lymph Nodes
100%
Low-dose Cyclophosphamide
100%
Lymph Node Cells
83%
Footpad
66%
Cyclophosphamide
50%
Lung Metastasis
50%
Cell number
33%
Lymphocytes
33%
Ionomycin
33%
Bryostatin
33%
Murine Model
16%
Cancer Patients
16%
In Cancer
16%
Antitumor Activity
16%
Tumor
16%
Lymph Node
16%
Interleukin-2
16%
Adoptive Transfer
16%
Syngeneic Mice
16%
Lung Tumor
16%
Sarcoma Cells
16%
Donor Groups
16%
In Vitro Activation
16%
Tail Vein
16%
Visceral Metastases
16%
Adoptive Immunotherapy
16%
In Vivo Antitumor Activity
16%
Popliteal Lymph Node
16%
Immunology and Microbiology
Immunosuppression
100%
Low Drug Dose
100%
Cyclophosphamide
100%
Lymph Node Cell
83%
Antineoplastic Activity
33%
Bryostatin 1
33%
Lymph Node
33%
Lymphocyte
33%
Popliteal Lymph Node
16%
Adoptive Immunotherapy
16%
Vein
16%
Cell Count
16%
Syngenic
16%
Sarcoma Cell
16%
Interleukin 2
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclophosphamide
100%
Lung Metastasis
50%
Antitumor Activity
33%
Ionomycin
33%
Bryostatin 1
33%
Neoplasm
33%
Malignant Neoplasm
16%
Lung Tumor
16%
Visceral Metastasis
16%
Immunotherapy
16%
Interleukin 2
16%
Connective Tissue Cancer
16%
Veterinary Science and Veterinary Medicine
Mouse
100%
Lymphocyte
33%
Tail Vein
16%
Connective Tissue Cancer
16%